Noninvasive Electrical Stimulator as a Pain Control Treatment Post-ureteroscopy

Trial ID or NCT#



not recruiting iconNOT RECRUITING


The investigators will assess the use of Transcutaneous Neurostimulation (TENS), a pharmacological alternative, for treatment of ureteral stent pain post-ureteroscopy. The primary aim for the investigators is to determine if use of a TENS unit will reduce post-operative pain and nausea associated with the ureteral stent. Secondary aim will be to assess if it can help minimize narcotic use.

Official Title

Noninvasive Electrical Stimulator as an Adjunct for Pain Control After Ureteroscopic Stone Management

Eligibility Criteria

Ages Eligible for Study: 18 Years to 70 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. * Adult patients undergoing standard of care ureteroscopy and laser lithotripsy for urinary stone disease* Patients receiving a stent following their ureteroscopy and laser lithotripsy
Exclusion Criteria:
  1. * Children* Pregnant patients* Patients unable to answer pain questionnaire* Patients undergoing PCNL* Patients being treated for Urologic malignancy with ureteroscopy* Patients who require long term or chronic ureteral stent management* Patient with implantable stimulators* Patient with epilepsy* Patients undergoing laser lithotripsy without stent placement


Simon Conti
Simon Conti
Clinical Associate Professor, Urology

Contact us to find out if this trial is right for you.


Simon Conti, MD